S1P in turn stimulates inter- and extracellular pro-inflammatory targets including the initial activating kinase ERK2 [59], leading to increased pancreatic cancer cell proliferation and drug resistance (Figure 11, left panel). Here, MAPK1 is linked to familial pancreatic carcinoma.